Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Li, Xiao Hong ^a   Gao, Chun Ji ^a   Da, Wan Ming ^a   Cao, Yong Bin ^a   Wang, Zhi Hong ^a   Xu, Li Xin ^a   Wu, Ya Mei ^a   Liu, Bei ^a   Liu, Zhou Yang ^a   Yan, Bei ^a   Li, Song Wei ^a   Yang, Xue Liang ^a   Wu, Xiao Xiong ^a   Han, Zhong Chao ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CD34 SELECTION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; MALE; MONONUCLEAR CELL; MORTALITY; NEUTROPHIL COUNT; OVERALL SURVIVAL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; SEVERE APLASTIC ANEMIA; STEM CELL MOBILIZATION; SURVIVAL RATE; THROMBOCYTE COUNT; UMBILICAL CORD BLOOD; VIREMIA; ANEMIA, APLASTIC; GRAFT VS HOST DISEASE; HAPLOINSUFFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HAPLOINSUFFICIENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84897083888     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089666     Document Type: Article

References (25)

1. Im HJ, Koh KN, Choi ES, Jang S, Kwon SW, et al. (2013) Excellent outcome of haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia. Biol Blood Marrow Transplant 19: 754-759.
2. Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, et al. (2007) Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood 109: 4582-4585. (Pubitemid 46743430)
3. Kang HJ, Shin HY, Park JE, Chung NG, Cho B, et al. (2010) Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study. Biol Blood Marrow Transplant 16: 1582-1588.
4. Battiwalla M, Wang T, Carreras J, Deeg HJ, Ayas M, et al. (2012) HLAmatched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival. Biol Blood Marrow Transplant 18: 1401-1406.
5. Maury S, Bacigalupo A, Anderlini P, Aljurf M, Marsh J, et al. (2009) Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen. Haematologica 94: 1312-1315.
6. Hussein AA, Frangoul H (2013) Less could be better: the case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia. Pediatr Transplant 17: 326-327.
7. Chung NG, Lee JW, Jang PS, Jeong DC, Cho B, et al. (2013) Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia. Pediatr Transplant 17: 387-393.
8. Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, et al. (2007) Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21: 1733-1738. (Pubitemid 47086763)
9. Fang B (2009) Poverty and biodiversity in rural areas based on two investigations in Pujiang County, China. J Environ Manage 90: 1924-1932.
10. Huang XJ, Chen YH, Xu LP, Zhang YC, Liu DH, et al. (2004) Combined transplantation of G-CSF primed allogeneic bone marrow cells and peripheral blood stem cells in treatment of severe aplastic anemia. Chin Med J (Engl) 117: 604-607.
11. Toya SP, Douskou M, Tomos P, Tzelepis GE (2007) Pulmonary sequestration diagnosed by multidetector computed tomographic angiography. Eur J Cardiothorac Surg 32: 535. (Pubitemid 47223733)
12. Ye RG, Lu ZY (2004) Internal Medicine. China: People's Health Publishing House.
13. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, et al. (2006) Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91: 1017-1026.
14. Kang M, Khandelwal N, Ojili V, Rao KL, Rana SS (2006) Multidetector CT angiography in pulmonary sequestration. J Comput Assist Tomogr 30: 926-932. (Pubitemid 44711481)
15. Viollier R, Passweg J, Gregor M, Favre G, Kuhne T, et al. (2005) Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia. Ann Hematol 84: 47-55. (Pubitemid 39618780)
16. Al-Zahrani H, Nassar A, Al-Mohareb F, Al-Sharif F, Mohamed S, et al. (2011) Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia. Biol Blood Marrow Transplant 17: 717-722.
17. Novitzky N, Thomas V, du Toit C, McDonald A (2009) Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD. Bone Marrow Transplant 43: 779-785.
18. Wu Y, Wang Z, Cao Y, Xu L, Li X, et al. (2013) Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy. Ann Hematol.
19. Frassoni F, Labopin M, Bacigalupo A (2002) Expanded mesenchymal stem cell (MSC) co-infused with HLA-identical hematopoietic stem cell transplants, reduced acute and chronic graft versus host disease: a matched pair analysis. Bone Marrow Transplant 29 (Suppl. 2).
20. Seong C, Durett A, Mirza N, Huh Y, Anderlini P, et al. (1997) Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors. Transfusion 37: 406-410. (Pubitemid 27193554)
21. Isola LM, Scigliano E, Skerrett D, Shank B, Ross V, et al. (1997) A pilot study of allogeneic bone marrow transplantation using related donors stimulated with GCSF. Bone Marrow Transplant 20: 1033-1037. (Pubitemid 28043414)
22. Bodine DM, Seidel NE, Orlic D (1996) Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 88: 89-97. (Pubitemid 26230675)
23. Ji SQ, Chen HR, Yan HM, Wang HX, Liu J, et al. (2005) Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies. Bone Marrow Transplant 36: 349-354. (Pubitemid 41195169)
24. Xu LP, Liu KY, Liu DH, Han W, Chen H, et al. (2012) A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia. Bone Marrow Transplant 47: 1507-1512.
25. Gezer S, Tastepe I, Sirmali M, Findik G, Turut H, et al. (2007) Pulmonary sequestration: a single-institutional series composed of 27 cases. J Thorac Cardiovasc Surg 133: 955-959. (Pubitemid 46435898)